An Informative Overview of Amicus Therapeutics a Biopharmaceutical Company
Amicus Therapeutics is not your average pharmaceutical company. It is a biopharmaceutical company that uses biologically generated drug treatment therapies to heal a person’s body. Biological components taken from blood, vaccines, gene therapies and bodily tissue process account for some of the primary biopharmaceutical treatments that are utilized by Amicus.
The thing that separates this organization form other pharmaceutical companies is their focus on the elimination of rare and orphan diseases. While they are not the only company that works to eliminate these conditions; this organization is leading the way in this field.
Amicus Therapeutics came into existence in 2002. They were founded by various venture companies that pooled their resources together to make the company a viable operation. The venture companies that founded Amicus consisted of Radius Ventures, Canaan Partners and New Enterprise Associates.
Orphan and rare diseases are not common but they still have the potential damage many people’s lives. Both of these disease types affect a small percentage of a population. They are also genetically based conditions. The researchers at Amicus develop their biopharmaceutical products to ensure that affected people have a fighting chance at recovering or managing their disease.
The company generates $18 million a year in revenues and it is a public organization. Amicus Therapeutics uses its own patented biopharmaceutical products to provide healing that patients need. Chaperone-Advanced Replacement Therapy or CHART is a specialized enzyme replacement therapy. It is a proven biopharmaceutical product.
John Crowley is the company’s CEO. He currently leads the organization at levels operation. Bradley Campbell is the Chief Operating Officer and the CFO is William Baird. These three men were chosen to run Amicus because of their biopharmaceutical knowledge and business acumen. Many people with rare and orphan diseases have been treated by Amicus Therapeutics. This organization continues to provide high quality care and solutions to some of the world’s toughest diseases.